Vital Signs - Lower is Better - A Blockbuster in Limbo
Vital Signs - Lower is Better - A Blockbuster in Limbo
RELEASE DATE
12-May-2008
12-May-2008
REGION
North America
North America
Research Code: 9561-00-61-00-00
SKU: HC00528-NA-MR_04000
$1,500.00
In stock
SKU
HC00528-NA-MR_04000
Description
This issue of Vital Signs, released on May 12, 2008, provides an strategic overview of current market issues facing Merck Schering-Plough's cholesterol drug, Vytorin. Additionally, a company spotlight is provided for Vical, a biopharmaceutical company developing medicines based on the company's proprietary DNA delivery technologies. Reimbursement and regulatory news from the FDA is also provided for the week of April 28 - May 2, 2008.
Table of Contents
This week's issue:
Popular Topics
This issue of Vital Signs, released on May 12, 2008, provides an strategic overview of current market issues facing Merck Schering-Plough's cholesterol drug, Vytorin. Additionally, a company spotlight is provided for Vical, a biopharmaceutical company developing medicines based on the company's proprietary DNA delivery technologies. Reimbursement and regulatory news from the FDA is also provided for the week of April 28 - May 2, 2008.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-61-00-00 |
Is Prebook | No |